Published in N Engl J Med on February 28, 1991
Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ (1994) 1.13
Endocrine adverse effects of omeprazole. BMJ (1992) 1.01
Transmucosal gastric leak induced by proton pump inhibitors. Dig Dis Sci (2008) 0.89
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol (2000) 0.78
Gynecomastia and drugs: a critical evaluation of the literature. Eur J Clin Pharmacol (2015) 0.75
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Twenty four hour manometric recording of colonic motor activity in healthy man. Gut (1987) 2.75
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.69
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
Gastric acidity and gastroesophageal reflux patterns in patients with esophagitis. Gastroenterology (1992) 1.58
Giardia lamblia infestation reveals underlying Whipple's disease in a patient with longstanding constipation. Am J Gastroenterol (1991) 1.48
Hepatitis B virus antigens in peripheral blood mononuclear cells during the course of viral infection. Clin Immunol Immunopathol (1994) 1.46
Selective endoscopic retrograde cholangiography and preoperative bile duct stone removal in patients scheduled for laparoscopic cholecystectomy: a prospective study. Am J Gastroenterol (1996) 1.45
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol (2007) 1.45
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis. Am J Gastroenterol (1990) 1.41
Interleukin 18 restores defective Th1 immunity to Candida albicans in caspase 1-deficient mice. Infect Immun (2000) 1.39
Esophageal motor disorders in patients evaluated for dysphagia and/or noncardiac chest pain. Dysphagia (1992) 1.39
Intragastric pH monitoring during antisecretory therapy in patient with gastrointestinal bleeding. Am J Gastroenterol (1989) 1.38
Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide. Dig Dis Sci (1986) 1.37
Colonic mass movements in idiopathic chronic constipation. Gut (1988) 1.36
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proc Natl Acad Sci U S A (2001) 1.31
The role of glial cells and apoptosis of enteric neurones in the neuropathology of intractable slow transit constipation. Gut (2005) 1.29
Human primary fibroblasts in vitro express a purinergic P2X7 receptor coupled to ion fluxes, microvesicle formation and IL-6 release. J Cell Sci (1999) 1.29
Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut (1994) 1.27
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats. Gastroenterology (1999) 1.24
Enhanced anti-inflammatory effects of a nitric oxide-releasing derivative of mesalamine in rats. Gastroenterology (1999) 1.22
Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology (1997) 1.22
Modulation of erythrocyte Ca2+-ATPase by selective calpain cleavage of the calmodulin-binding domain. J Biol Chem (1989) 1.18
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol (2000) 1.14
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity. Proc Natl Acad Sci U S A (2001) 1.14
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. J Immunol (2000) 1.14
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology (2000) 1.13
Molecular characterization of inherited carnitine palmitoyltransferase II deficiency. Proc Natl Acad Sci U S A (1992) 1.13
Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE). Dig Liver Dis (2005) 1.13
Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology (1995) 1.10
Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum (1997) 1.09
Biofeedback for pelvic floor dysfunction in constipation. BMJ (2004) 1.09
Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07
The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J (2000) 1.06
Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity. Cancer Res (1985) 1.05
21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties. Br J Pharmacol (2000) 1.04
Cardiac protection by volatile anesthetics in non-cardiac surgery? A meta-analysis of randomized controlled studies on clinically relevant endpoints. HSR Proc Intensive Care Cardiovasc Anesth (2009) 1.03
Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine-sensitized mice. Gastroenterology (1996) 1.03
In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol (2002) 1.03
Identification of muscarinic receptor subtype mediating colonic response to eating. Dig Dis Sci (1985) 1.03
Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest (1997) 1.00
Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology (2000) 1.00
False positive EBNA IgM and IgG antibody tests for infectious mononucleosis in children. Pediatrics (1994) 1.00
Clinical and histological features of a group of patients with sporadic non-A, non-B hepatitis. J Clin Pathol (1981) 1.00
Upper gastrointestinal motor activity in patients with slow-transit constipation. Further evidence for an enteric neuropathy. Dig Dis Sci (1996) 0.99
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut (2006) 0.99
Mechanism of non-steroidal anti-inflammatory drug-gastropathy. Dig Liver Dis (2001) 0.98
Effect of omeprazole on gastroesophageal reflux in Barrett's esophagus. Am J Gastroenterol (1989) 0.98
Upper gastrointestinal motor abnormalities in children with active celiac disease. J Pediatr Gastroenterol Nutr (1995) 0.97
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Eur J Immunol (1995) 0.97
Impaired colonic motor response to cholinergic stimulation in patients with severe chronic idiopathic (slow transit type) constipation. Dig Dis Sci (1993) 0.97
Biochemical mechanisms of glucose-6-phosphate dehydrogenase deficiency. Proc Natl Acad Sci U S A (1978) 0.96
Human colonic motility: physiological aspects. Int J Colorectal Dis (1995) 0.95
Edrophonium chloride for testing colonic contractile activity in man. Acta Physiol Scand (1991) 0.95
Interstitial cells of Cajal, enteric nerves, and glial cells in colonic diverticular disease. J Clin Pathol (2005) 0.94
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. Br J Pharmacol (2001) 0.94
Flow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term culture. Immunology (1996) 0.94
Transition from nutcracker esophagus to diffuse esophageal spasm. Am J Gastroenterol (1985) 0.94
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalpha. Aliment Pharmacol Ther (1999) 0.94
Diagnostic accuracy of bedside ultrasonography in the ICU: feasibility of detecting pulmonary effusion and lung contusion in patients on respiratory support after severe blunt thoracic trauma. Acta Anaesthesiol Scand (2008) 0.94
Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf (2001) 0.93
First results from the XENON10 dark matter experiment at the Gran Sasso National Laboratory. Phys Rev Lett (2008) 0.93
Duodenojejunal motor activity in patients with chronic dyspeptic symptoms. J Clin Gastroenterol (1990) 0.93
Distension-stimulated propagated contractions in human colon. Dig Dis Sci (1994) 0.93
Intestinal pseudoobstruction secondary to hypothyroidism. Importance of small bowel manometry. J Clin Gastroenterol (1992) 0.92
Severe gastric mucosal damage induced by NSAIDs in healthy subjects is associated with Helicobacter pylori infection and high levels of serum pepsinogens. Dig Dis Sci (1995) 0.92
Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide. Digestion (1987) 0.92
Impaired colonic motor response to eating in patients with slow-transit constipation. Am J Gastroenterol (1992) 0.92
Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol (1995) 0.91
Circadian variations in gastric acid and pepsin secretion and intragastric bile acid in patients with reflux esophagitis and in healthy controls. Am J Gastroenterol (1995) 0.91
Human erythrocyte glucose 6-phosphate dehydrogenase. Content of bound coenzyme. Biochem Biophys Res Commun (1974) 0.90
Castleman's disease: an unusual cause of mediastinal mass and anemia. Clin Ter (2002) 0.90
NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon. Dig Liver Dis (2007) 0.90
Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study. Aliment Pharmacol Ther (2006) 0.90
Gluten-free diet normalizes mouth-to-cecum transit of a caloric meal in adult patients with celiac disease. Dig Dis Sci (1997) 0.89
A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers. Br J Rheumatol (1996) 0.89